 VICTORIA and UTRECHT, The Netherlands , Jan. 9, 2020 CNW - IMMUNOPRECISE ANTIBODIES LTD. the Company or IPA TSX VENTURE: IPA OTC QB: IPATF a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, today announced that its wholly owned subsidiary U-Protein Express BV signed a long-term lease contract for the new multi-tenant building for life sciences Accelerator at the Utrecht Science Park Utrecht, The Netherlands . In addition to accommodating large biotechnology companies, the new building will offer space to companies that want to accelerate their development. 